References
- Björck M, Earnshaw JJ, Acosta S, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. Eur J Vasc Endovasc Surg. 2020;59(2):173–218. doi: 10.1016/j.ejvs.2019.09.006
- Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S–125S.e40. doi: 10.1016/j.jvs.2019.02.016
- Lisman T. Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease. Cell Tissue Res. 2018;371(3):567–576. doi: 10.1007/s00441-017-2727-4
- Jakobsson G, Papareddy P, Andersson H, et al. Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction. Critical Care. 2023;27(1):374. doi: 10.1186/s13054-023-04652-x
- Boteanu RM, Suica VI, Uyy E, et al. Short-Term Blockade of Pro-Inflammatory Alarmin S100A9 Favorably Modulates Left Ventricle Proteome and Related Signaling Pathways Involved in Post-Myocardial Infarction Recovery. Int J Mol Sci. 2022;23(9):5289. doi: 10.3390/ijms23095289
- Marinković G, Koenis DS, de Camp L, et al. S100A9 Links Inflammation and Repair in Myocardial Infarction. Circ Res. 2020;127(5):664–676. doi: 10.1161/CIRCRESAHA.120.315865
- Zuidema MY, Zhang C. Ischemia/reperfusion injury: The role of immune cells. World J Cardiol. 2010;2(10):325–332. doi: 10.4330/wjc.v2.i10.325
- Stabile E, Kinnaird T, la Sala A, et al. CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16. Circulation. 2006;113(1):118–124. doi: 10.1161/CIRCULATIONAHA.105.576702
- Kaller R, Russu E, Arbănași EM, et al. Intimal CD31-Positive Relative Surfaces Are Associated with Systemic Inflammatory Markers and Maturation of Arteriovenous Fistula in Dialysis Patients. Journal of Clinical Medicine. 2023;12(13):4419. doi: 10.3390/jcm12134419
- Mureșan AV, Russu E, Arbănași EM, et al. The Predictive Value of NLR, MLR, and PLR in the Outcome of End-Stage Kidney Disease Patients. Biomedicines. 2022;10(6):1272. doi: 10.3390/biomedicines10061272
- Kaller R, Arbănași EM, Mureșan AV, et al. The Predictive Value of Systemic Inflammatory Markers, the Prognostic Nutritional Index, and Measured Vessels' Diameters in Arteriovenous Fistula Maturation Failure. Life. 2022;12(9):1447. doi: 10.3390/life12091447
- Niculescu R, Russu E, Arbănași EM, et al. Carotid Plaque Features and Inflammatory Biomarkers as Predictors of Restenosis and Mortality Following Carotid Endarterectomy. International Journal of Environmental Research and Public Health. 2022;19(21):13934. doi: 10.3390/ijerph192113934
- Arbănași EM, Mureșan AV, Arbănași EM, et al. The Neutrophilto-Lymphocyte Ratio's Predictive Utility in Acute Pulmonary Embolism: Systematic Review. Journal of Cardiovascular Emergencies. 2022;8:25–30. doi: 10.2478/jce-2022-0005
- Mureșan AV, Hălmaciu I, Arbănași EM, et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(11):2757. doi: 10.3390/diagnostics12112757
- Halmaciu I, Arbănași EM, Kaller R, et al. Chest CT Severity Score and Systemic Inflammatory Biomarkers as Predictors of the Need for Invasive Mechanical Ventilation and of COVID-19 Patients' Mortality. Diagnostics. 2022;12(9):2089. doi: 10.3390/diagnostics12092089
- Arbănași EM, Halmaciu I, Kaller R, et al. Systemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(10):2379. doi: 10.3390/diagnostics12102379
- Melinte RM, Arbănași EM, Blesneac A, et al. Inflammatory Biomarkers as Prognostic Factors of Acute Deep Vein Thrombosis Following the Total Knee Arthroplasty. Medicina. 2022;58(10):1502. doi: 10.3390/medicina58101502
- Vunvulea V, Budișcă OA, Arbănași EM, et al. The Predictive Role of Systemic Inflammatory Markers in the Development of Acute Kidney Failure and Mortality in Patients with Abdominal Trauma. Journal of Personalized Medicine. 2022;12(12):2045. doi: 10.3390/jpm12122045
- Arbănași EM, Kaller R, Mureșan AV, Voidăzan S, Arbanasi EM, Russu E. Impact of COVID-19 pandemic on Vascular Surgery Unit activity in Central Romania. Front Surg. 2022;9:883935. doi: 10.3389/fsurg.2022.883935
- Hodas R, Benedek I, Rat N, Kovacs I, Chitu M, Benedek T. Impact of COVID-19 Pandemic on STEMI Networks in Central Romania. Life. 2021;11(10):1004. doi: 10.3390/life11101004
- Bhargavan B, Kanmogne GD. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Induce P-Selectin and Markers of Endothelial Injury, NETosis, and Inflammation in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for the Pathogenesis of COVID-19 Coagulopathy. Int J Mol Sci. 2023;24(16):12585. doi: 10.3390/ijms241612585
- Mátyás BB, Benedek I, Blîndu E, et al. Elevated FAI Index of Pericoronary Inflammation on Coronary CT Identifies Increased Risk of Coronary Plaque Vulnerability after COVID-19 Infection. Int J Mol Sci. 2023;24(8):7398. doi: 10.3390/ijms24087398
- Ranucci M, Baryshnikova E, Anguissola M, Pugliese S, Falco M, Menicanti L. The Long Term Residual Effects of COVID-Associated Coagulopathy. International Journal of Molecular Sciences. 2023;24(6):5514. doi: 10.3390/ijms24065514
- Szilveszter M, Pál S, Simon-Szabó Z, et al. The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases. International Journal of Molecular Sciences. 2023;24(16):12782. doi: 10.3390/ijms241612782
- Ragnoli B, Da Re B, Galantino A, Kette S, Salotti A, Malerba M. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence. Int J Mol Sci. 2023;24(10):8945. doi: 10.3390/ijms24108945
- Wada H, Shiraki K, Shimpo H, Shimaoka M, Iba T, Suzuki-Inoue K. Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019. International Journal of Molecular Sciences. 2023;24(9):7975. doi: 10.3390/ijms24097975
- Taşoğlu I, Çiçek OF, Lafci G, et al. Usefulness of neutrophil/lymphocyte ratio as a predictor of amputation after embolectomy for acute limb ischemia. Ann Vasc Surg. 2014;28(3):606–613. doi: 10.1016/j.avsg.2012.12.009
- Coelho NH, Coelho A, Augusto R, et al. Pre-operative Neutrophil to Lymphocyte Ratio is Associated With 30 Day Death or Amputation After Revascularisation for Acute Limb Ischaemia. Eur J Vasc Endovasc Surg. 2021;62(1):74–80. doi: 10.1016/j.ejvs.2021.03.011
- Taurino M, Aloisi F, Del Porto F, et al. Neutrophil-to-Lymphocyte Ratio Could Predict Outcome in Patients Presenting with Acute Limb Ischemia. Journal of Clinical Medicine. 2021;10(19):4343. doi: 10.3390/jcm10194343
- Pasqui E, de Donato G, Giannace G, et al. The relation between neutrophil/lymphocyte and platelet/lymphocyte ratios with mortality and limb amputation after acute limb ischaemia. Vascular. 2022;30(2):267–275. doi: 10.1177/17085381211010012
- Arbănași EM, Mureșan AV, Coșarcă CM, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Impact on Predicting Outcomes in Patients with Acute Limb Ischemia. Life. 2022;12(6):822. doi: 10.3390/life12060822
- Spark JI, Sarveswaran J, Blest N, Charalabidis P, Asthana S. An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. Journal of Vascular Surgery. 2010;52(3):632–636. doi: 10.1016/j.jvs.2010.03.067
- Chan C, Puckridge P, Ullah S, Delaney C, Spark JI. Neutrophil-lymphocyte ratio as a prognostic marker of outcome in infrapopliteal percutaneous interventions for critical limb ischemia. Journal of Vascular Surgery. 2014;60(3):661–668. doi: 10.1016/j.jvs.2014.03.277
- González-Fajardo JA, Brizuela-Sanz JA, Aguirre-Gervás B, et al. Prognostic Significance of an Elevated Neutrophil–Lymphocyte Ratio in the Amputation-free Survival of Patients with Chronic Critical Limb Ischemia. Annals of Vascular Surgery. 2014;28(4):999–1004. doi: 10.1016/j.avsg.2013.06.037
- Erturk M, Cakmak HA, Surgit O, et al. Predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease. J Cardiol. 2014;64(5):371–376. doi: 10.1016/j.jjcc.2014.02.019
- Taşoğlu İ, Sert D, Colak N, Uzun A, Songur M, Ecevit A. Neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio predict the limb survival in critical limb ischemia. Clin Appl Thromb Hemost. 2014;20(6):645–650. doi: 10.1177/1076029613475474
- Su MI, Liu CW. Neutrophil-to-lymphocyte ratio associated with an increased risk of mortality in patients with critical limb ischemia. PLOS ONE. 2021;16(5):e0252030. doi: 10.1371/journal.pone.0252030
- Russu E, Mureșan AV, Arbănași EM, et al. The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease. Journal of Clinical Medicine. 2022;11(9):2620. doi: 10.3390/jcm11092620
- Chen C, Gu L, Chen L, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Potential Predictors of Prognosis in Acute Ischemic Stroke. Front Neurol. 2021;11:525621. doi: 10.3389/fneur.2020.525621
- Brooks SD, Spears C, Cummings C, et al. Admission neutrophil–lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy. J Neurointerv Surg. 2014;6(8):578–583. doi: 10.1136/neurintsurg-2013-010780
- Xu C, Cai L, Yi T, Yi X, Hu Y. Neutrophil-to-lymphocyte ratio is associated with stroke progression and functional outcome in patients with ischemic stroke. Brain Behav. 2023;13(11):e3261. doi: 10.1002/brb3.3261
- Kordzadeh A, Malietzis G, Browne T, Prionidis I, Panayiotopoulos YP. Neutrophil to lymphocyte ratio (NLR) of five predicts 30-day morbidity in ruptured abdominal aortic aneurysms (rAAA): A retrospective cohort study. Int J Surg. 2015;15:45–48. doi: 10.1016/j.ijsu.2015.01.013
- Aurelian SV, Adrian M, Andercou O, et al. Neutrophil-to-Lymphocyte Ratio: A Comparative Study of Rupture to Nonruptured Infrarenal Abdominal Aortic Aneurysm. Ann Vasc Surg. 2019;58:270–275. doi: 10.1016/j.avsg.2018.11.026
- Appleton ND, Bailey DM, Morris-Stiff G, Lewis MH. Neutrophil to Lymphocyte Ratio Predicts Perioperative Mortality Following Open Elective Repair of Abdominal Aortic Aneurysms. Vasc Endovasc Surg. 2014;48(4):311–316. doi: 10.1177/1538574413519713
- Mares RG, Marinkovic G, Cotoi OS, Schiopu A. Innate Immune Mechanisms in Myocardial Infarction – An Update. Rev Romana Med Lab. 2017;26(1):9–20. doi: 10.1515/rrlm-2017-0031
- Mares RG, Manu D, Szabo IA, et al. Studying the Innate Immune Response to Myocardial Infarction in a Highly Efficient Experimental Animal Model. Romanian Journal of Cardiology. 2021;31(3):573–585. doi: 10.47803/rjc.2021.31.3.573
- Mares R, Sabău A, Cocuz I, et al. S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction. Romanian Journal of Morphology and Embryology. 2023;64:151–158. doi: 10.47162/RJME.64.2.04
- Schiopu A, Björkbacka H, Narasimhan G, et al. Elevated soluble LOX-1 predicts risk of first-time myocardial infarction. Ann Med. 2023;55(2):2296552. doi: 10.1080/07853890.2023.2296552
- Grufman H, Yndigegn T, Gonçalves I, Nilsson J, Schiopu A. Elevated IL-27 in patients with acute coronary syndrome is associated with adverse ventricular remodeling and increased risk of recurrent myocardial infarction and cardiovascular death. Cytokine. 2019;122:154208. doi: 10.1016/j.cyto.2017.11.002
- Marinković G, Grauen Larsen H, Yndigegn T, et al. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction. Eur Heart J. 2019;40(32):2713–2723. doi: 10.1093/eurheartj/ehz461
- Jalbani J, Bhatti KI, Sallar MT, et al. The Role of Neutrophil to Lymphocyte Ratio and its Common Clinical Outcomes Among Patients with Non-ST Elevation Acute Coronary Syndrome. J Saudi Heart Assoc. 2023;35(2):177–182. doi: 10.37616/2212-5043.1340
- Tudurachi BS, Anghel L, Tudurachi A, Sascău RA, Stătescu C. Assessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients. Int J Mol Sci. 2023;24(18):14378. doi: 10.3390/ijms241814378
- Khan UH, Pala MR, Hafeez I, Shabir A, Dhar A, Rather HA. Prognostic value of hematological parameters in older adult patients with acute coronary syndrome undergoing coronary intervention: a single centre prospective study. J Geriatr Cardiol. 2023;20(8):596–601. doi: 10.26599/1671-5411.2023.08.008
- Ha ET, Yee A, Peterson SJ, et al. Neutrophil-to-lymphocyte ratio and prognosis in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Cardiovascular Revascularization Medicine. Published online September 12, 2023. doi: 10.1016/j.carrev.2023.09.003
- Wang W, Liu L, Ning Z, Che L, Li X. The neutrophil-lymphocyte ratio to predict poor prognosis of critical acute myocardial infarction patients: a retrospective cohort study. Biochem Med (Zagreb). 2023;33(1):010702. doi: 10.11613/BM.2023.010702
- Shumilah AM, Othman AM, Al-Madhagi AK. Accuracy of neutrophil to lymphocyte and monocyte to lymphocyte ratios as new inflammatory markers in acute coronary syndrome. BMC Cardiovasc Disord. 2021;21(1):422. doi: 10.1186/s12872-021-02236-7